BNP Paribas Financial Markets
CAMP icon

BNP Paribas Financial Markets’s CAMP4 Therapeutics CAMP Stock Holding History

BNP Paribas Financial Markets’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$159 Buy
36
+3
+9% +$14 ﹤0.01% 5646
2025
Q4 		$202 Sell
33
-45
-58% -$191 ﹤0.01% 5567
2025
Q3 		$234 Sell
78
-349
-82% -$646 ﹤0.01% 5375
2025
Q2 		$619 Buy
427
+215
+101% +$428 ﹤0.01% 5203
2025
Q1 		$848 Sell
212
-326
-61% -$1.58K ﹤0.01% 5087
2024
Q4 		$2.81K Buy
+538
New +$4.42K ﹤0.01% 4982

Other funds holding CAMP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BNP Paribas Financial Markets's CAMP Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its CAMP4 Therapeutics (CAMP) stake by 9.1% in Q1 2026, buying an estimated $14 and bringing the position to 36 shares worth $159. The position accounts for ﹤0.01% of the portfolio, ranked #5646.

BNP Paribas Financial Markets first reported a position in CAMP in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.81K in Q4 2024. 46 funds tracked by Wall St. Rank hold CAMP as of Q1 2026.

  • BNP Paribas Financial Markets held 36 shares of CAMP4 Therapeutics worth $159 as of Q1 2026.
  • BNP Paribas Financial Markets bought 3 CAMP4 Therapeutics shares in Q1 2026, an estimated $14.
  • CAMP4 Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5646 holding.
  • BNP Paribas Financial Markets first reported a position in CAMP4 Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's CAMP4 Therapeutics position peaked at $2.81K in Q4 2024.
  • 46 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.